145 related articles for article (PubMed ID: 27458297)
1. Accuracy of Prostate-Specific Antigen Values in Prostate Cancer Registries.
Mittakanti HR; Thomas IC; Shelton JB; Makarov DV; Skolarus TA; Cooperberg MR; Chung BI; Sonn GA; Brooks JD; Leppert JT
J Clin Oncol; 2016 Oct; 34(29):3586-3587. PubMed ID: 27458297
[No Abstract] [Full Text] [Related]
2. Increase in Prostate Cancer Metastases at Radical Prostatectomy in the United States.
Hu JC; Nanus DM; Sedrakyan A
Eur Urol; 2017 Jan; 71(1):147-149. PubMed ID: 27402061
[No Abstract] [Full Text] [Related]
3. Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States.
Hu JC; Nguyen P; Mao J; Halpern J; Shoag J; Wright JD; Sedrakyan A
JAMA Oncol; 2017 May; 3(5):705-707. PubMed ID: 28033446
[TBL] [Abstract][Full Text] [Related]
4. What is a "Diagnostic Test Reference Range" Good for?
Habibzadeh P; Yadollahie M; Habibzadeh F
Eur Urol; 2017 Nov; 72(5):859-860. PubMed ID: 28558944
[No Abstract] [Full Text] [Related]
5. Prostate cancer options expand beyond the PSA.
Clin Resour Manag; 2002 May; 3(5):65-8. PubMed ID: 12048767
[No Abstract] [Full Text] [Related]
6. Efficacy of Prostate-Specific Antigen Screening: Use of Regression Discontinuity in the PLCO Cancer Screening Trial.
Shoag J; Halpern J; Eisner B; Lee R; Mittal S; Barbieri CE; Shoag D
JAMA Oncol; 2015 Oct; 1(7):984-6. PubMed ID: 26291583
[No Abstract] [Full Text] [Related]
7. Prostate-specific antigen screening for prostate cancer in males older than 75 years.
Luján M; Páez Á
Med Clin (Barc); 2019 Mar; 152(6):237-240. PubMed ID: 30220470
[No Abstract] [Full Text] [Related]
8. Validation of prostate-specific antigen laboratory values recorded in Surveillance, Epidemiology, and End Results registries.
; Adamo MP; Boten JA; Coyle LM; Cronin KA; Lam CJ; Negoita S; Penberthy L; Stevens JL; Ward KC
Cancer; 2017 Feb; 123(4):697-703. PubMed ID: 27783399
[TBL] [Abstract][Full Text] [Related]
9. Prostate specific antigen testing: age-related interpretation in early prostate cancer detection.
McKenzie PR; Delahunt B; Kench JG; Ross B; Lam Q; deVoss K; Tran HA; Sikaris KA
Pathology; 2013 Jun; 45(4):343-5. PubMed ID: 23619589
[No Abstract] [Full Text] [Related]
10. Managing localized prostate cancer in the era of prostate-specific antigen screening.
Brooks JD
Cancer; 2013 Nov; 119(22):3906-9. PubMed ID: 24006273
[TBL] [Abstract][Full Text] [Related]
11. The New US Preventive Services Task Force "C" Draft Recommendation for Prostate Cancer Screening.
Cooperberg MR
Eur Urol; 2017 Sep; 72(3):326-328. PubMed ID: 28535948
[TBL] [Abstract][Full Text] [Related]
12. Delayed clinician responses to elevated prostate-specific antigen values.
Sinsky T; Sinsky C; Wahls TL
Mayo Clin Proc; 2008 Aug; 83(8):961-2; author reply 962. PubMed ID: 18674482
[No Abstract] [Full Text] [Related]
13. Re: The Value of Magnetic Resonance Imaging in the Detection of Prostate Cancer in Patients with Previous Negative Biopsies and Elevated Prostate-Specific Antigen Levels: A Meta-Analysis.
Siegel C
J Urol; 2015 Aug; 194(2):395. PubMed ID: 26195367
[No Abstract] [Full Text] [Related]
14. Accuracy of the preoperative PSA level for predicting clinically significant incidental transitional zone-prostate cancer before endoscopic enucleation of very large adenoma.
Misraï V; Pasquie M; Bordier B; Guillotreau J; Gryn A; Palasse J; Bruguière E; Pradere B; Rouprêt M; Zorn KC
World J Urol; 2020 Apr; 38(4):993-1000. PubMed ID: 31139906
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer: is the PSA test the answer?
Berlin B
N J Med; 1998 Mar; 95(3):53-5. PubMed ID: 16013148
[No Abstract] [Full Text] [Related]
16. Early-stage prostate cancer, PSA screening rates decline.
Printz C
Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
[No Abstract] [Full Text] [Related]
17. Studies of prostate-cancer mortality: caution advised.
Etzioni R; Feuer E
Lancet Oncol; 2008 May; 9(5):407-9. PubMed ID: 18452850
[No Abstract] [Full Text] [Related]
18. Prostate kallikrein markers in diagnosis, risk stratification and prognosis.
Ulmert D; O'Brien MF; Bjartell AS; Lilja H
Nat Rev Urol; 2009 Jul; 6(7):384-91. PubMed ID: 19578355
[TBL] [Abstract][Full Text] [Related]
19. Re: The Impact of Obesity on the Predictive Accuracy of PSA in Men Undergoing Prostate Biopsy.
Kaplan SA
J Urol; 2015 Aug; 194(2):394-5. PubMed ID: 26195366
[No Abstract] [Full Text] [Related]
20. Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer.
Mahal BA; Yang DD; Wang NQ; Alshalalfa M; Davicioni E; Choeurng V; Schaeffer EM; Ross AE; Spratt DE; Den RB; Martin NE; Mouw KW; Orio PF; Choueiri TK; Taplin ME; Trinh QD; Feng FY; Nguyen PL
Eur Urol; 2018 Aug; 74(2):146-154. PubMed ID: 29478736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
